Yüklüyor......
Update on clinical research and state of the art management of patients with advanced sarcomas and GIST
Sarcomas constitute a rare group of malignancies. According to histology, different treatment options are effective. For gastrointestinal stromal tumours (GISTs), targeted treatment with imatinib controls about 20% of advanced or metastatic disease, whereas chemotherapy is more effective for the res...
Kaydedildi:
| Yayımlandı: | ESMO Open |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070248/ https://ncbi.nlm.nih.gov/pubmed/27843616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000065 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|